FORVITE® BREWERS YEAST TABLETS

Patient Information leaflet

                                INDICATIONS [/za_1120.html#1]
  [/za_1120.html#1]     [/za_1120.html#1]
CONTRA-INDICATIONS [/za_1120.html#1]
      [/za_1120.html#1]
DOSAGE [/za_1120.html#1]
      [/za_1120.html#1]
SIDE-EFFECTS [/za_1120.html#1]
  [/za_1120.html#1]    PREGNANCY      [/za_1120.html#1]
OVERDOSE [/za_1120.html#1]
    
IDENTIFICATION [/za_1120.html#1]
  [/za_1120.html#1]    PATIENT INFORMATION
FORVITE® BREWERS YEAST TABLETS
SCHEDULING STATUS:
Unscheduled
PROPRIETARY NAME
(and dosage form):
FORVITE
®
 BREWERS YEAST TABLETS
COMPOSITION:
Each tablet contains: Dried 
BREWERS YEAST
 450 mg
PHARMACOLOGICAL CLASSIFICATION:
A 22.1.4 Vitamins - Other.
PHARMACOLOGICAL ACTION :
Source of B group vitamins and protein.
INDICATIONS:
For the prevention and treatment of vitamin B deficiency. 
CONTRA-INDICATIONS:
None.
DOSAGE AND DIRECTIONS FOR USE:
Take two to three tablets three times a day.
SIDE-EFFECTS AND SPECIAL PRECAUTIONS:
None, if taken as directed.
KNOWN SYMPTOMS OF OVERDOSAGE AND PARTICULARS OF ITS TREATMENT:
None.
IDENTIFICATION:
Brown biconvex tablets.
PRESENTATION:
Packs of 100, 500 and 1000 tablets.
STORAGE INSTRUCTIONS:
Store below 25°C.
Protect from light and moisture.
KEEP OUT OF REACH OF CHILDREN.
APPLICATION NUMBER:
H2046 (Act 101/1965)
NAME AND BUSINESS ADDRESS OF APPLICANT:
Lennon Limited
7 Fairclough Road 
PORT ELIZABETH
6001
DATE OF PUBLICATION OF THIS PACKAGE INSERT:
25.11.1974. P567
SAEPI HOME PAGE [/pharm]
  [/pharm]      [/pharm/index/index_T_A.shtml]
TRADE NAME INDEX [/pharm/index/index_T_A.shtml]
       [/pharm/index/index_G_A.shtml]
GENERIC NAME INDEX [/pharm/index/index_G_A.shtml]
       [/pharm/feedback.html]
FEEDBACK [/pharm/feedback.html]
  [/pharm/feedback.html]
Information presented by Malahyde Information Systems © Copyright 1996,1997,1998
                                
                                Read the complete document